Food additive composition |
| OF THE PREFERRED EMBODIMENTS The present invention is directed to food supplement compositions ... |
|
Method for chemoprevention of prostate cancer |
| This invention related to a method for preventing prostate carcinogenesis of a subject comprising: ... |
|
Placental alkaline phosphatase to control diabetes |
| In one embodiment, the present invention provides a method of reducing plasma glucose level in a ... |
|
Process for producing malt alcoholic drink |
| The invention claimed is: 1. A method of producing a malt alcohol beverage, comprising: removing ... |
|
Delivery of controlled-release system (s) |
| OF THE INVENTION The present invention is a method of making comestible units which disintegrate ... |
|
Composition for the treatment of cutaneous mycosis |
| I claim: 1. An antifungal powder composition for the treatment of cutaneous mycosis that consists ... |
|
Sustained release compositions for treating periodontal disease |
| OF THE INVENTION The essential as well as optional components of the compositions of this ... |
|
Prevention of crystal formation in toothpaste |
| OF THE INVENTION The dentifrices of the present invention include toothpastes, dental creams, or ... |
|
|
Pharmaceutical compositions and preparations thereof
| Details |
Inventors: Snyckers, Friedrich O.; Fourie, Theunis G.;
Assignee: 501 Noristan Limited (ZA)
Primary Examiner: Waddell; Frederick E.
Assistant Examiner:
Attorney, Agent or Firm: Berman, Aisenberg & Platt
The invention provides oleanolic acid and/or a physiologically acceptable salt thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach and/or intestines. The ulcerogenic disorders can be of the type chemically induced and/or stress-induced. The invention also provides a pharmaceutical composition comprising an active amount of oleanolic acid and/or a physiologically acceptable salt thereof in combination with an analgesic compound and/or an anti-inflammatory compound. The invention further provides for use of oleanolic acid in preventing and/or significantly reducing and/or therapeutically treating ulcerogenic-type disorders of the stomach and/or intestines. |
|
DETAILED DESCRIPTION OF THE INVENTION The invention and its various aspects will now be described hereunder. Examples 1 and 2 are not to be regarded as part of the invention but are intended rather for information and background. EXAMPLE 1 Preparation of Oleanolic Acid Suitable plant material, for example grape husks (preferably dried and milled), is exhaustively extracted with such solvents in which oleanolic acid is soluble. These include: aromatic solvents, such as benzene; esters, such as ethyl acetate; ketones, such as acetone; halogenated hydrocarbons, such as chloroform and dichloromethane; alcohols, such as methanol and ethanol; ethers, such as diethyl ether or dioxane; and mixtures thereof. Preferably the extractions are performed with chloroform, dichloromethane, ethanol, or methanol, or mixtures thereof. From these extracts, the oleanolic acid can be separated by any method known in the art. Preferably the extracts are treated with sufficient aqueous base to effect conversion into a water soluble salt of oleanolic acid. Preferably a diluted sodium hydroxide solution is used for this purpose. The aqueous solution of this salt is now treated with a suitable water immiscible solvent (such as dichloromethane or diethyl ether) to remove the bulk of the non-acidic components from the aqueous phase. The purified aqueous solution containing the salt of oleanolic acid is now acidified with a suitable acid (preferably hydrochloric or sulphuric acid), to reconvert the salt to oleanolic acid. The crude oleanolic acid can now be recovered by filtration or sedimentation, but preferably by extraction with a solvent which is not water miscible but which is a good solvent for oleanolic acid (preferably dichloromethane or diethyl ether), and subsequent evaporation of that extract. Purification of the crude oleanolic acid can be achieved by recrystallisation or chromatography. EXAMPLE 2 Preparation of Sodium Oleanolate A 10% aqueous solution of sodium hydroxide is added to an almost saturated solution of oleanolic acid in a water immiscible solvent, for example dichloromethane or diethyl ether
|
| Related patents |
|
|
Pain reliever and method of use
OF THE PREFERRED EMBODIMENTS Capsaicin is trans-8-methyl-N-vanillyl-5 nonenamide, a naturally occurring alkyl vanillylamide, a type of capsaicinoid. It is found in high ...
|
|
|
Burn and wound ointment
We claim: 1. An ointment for the treatment of burns and wounds in mammals, which comprises:
______________________________________
celandine Chelidonium ...
|
|
|
Dietary supplement containing saw palmetto, pumpkin seed, and nettle root
OF THE PREFERRED EMBODIMENTS This invention is directed to a dietary supplement for use in supporting and maintaining normal prostrate gland function. The dietary ...
|
|
|
Method and apparatus for preparing a dairy product
The residence time of the starter culture in the pre-incubator is preferably from about 10 to about 60 minutes, more preferably from about 10 to about 30 minutes and ...
|
|
|
2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
"Lower alkyl of from one to four" or "ten carbons" in the present invention means methyl, ethyl, propyl, butyl or further pentyl, hexyl, heptyl or the like and isomers ...
|
|
|
1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
What is claimed is: 1. A compound of Formula I ##STR7## wherein R.sup.1 is alkylsulfonyl or sulfamyl; wherein R.sup.2 is aryl; wherein R.sup.2 is optionally substituted ...
|
|
|
N-benzyl-3-indoleacetic acids as antiinflammatory drugs
OF THE INVENTION The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration ...
|
|
|
Method for chemoprevention of prostate cancer
This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of a chemopreventive ...
|
|
|
Method for chemoprevention of prostate cancer
This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of an antiestrogen to ...
|
|
|
Method for chemoprevention of prostate cancer
This invention relates to the chemoprevention of prostate cancer and, more particularly, to a method of suppressing or inhibiting latent prostate cancer comprising the ...
|
|
|